Class Action News

TAL Education Class Action Lawsuit Deadline Approaches

zlk2_asuka

June 22, 2018

To: All persons or entities who purchased or otherwise acquired securities of TAL Education Group (“TAL Education”) (NYSE: TAL) between April 26, 2018 and June 13, 2018. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Southern District of New York. To get more information on the TAL Education lawsuit (TAL lawsuit) go to: http://www.zlk.com/pslra-d/tal-education-group or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

 

The Tal Education class action complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) the Company overstated its net income; (2) the Company’s net income was deteriorating; and (3) as a result of the foregoing, Defendants’ statements about TAL’s business, operations, and prospects, were materially false and/or misleading and/or lacked a reasonable basis.

 

On June 13, 2018, Muddy Waters website published a report alleging that TAL has been fraudulently overstating its profits since at least the fiscal year 2016. On this news, shares of TAL Education fell from a close of $45.65 on June 12, 2018, to a close of $38.74 on June 15, 2018.

 

If you suffered a loss in TAL Education you have until August 17, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.